Cargando…

Maximizing Completion of the Two-Dose COVID-19 Vaccine Series with Aid from Infographics

Two of the three COVID-19 vaccines approved in the United States require two doses to reach full efficacy, as do others available elsewhere in the world. The complete series of multidose COVID-19 vaccines offers stronger protection against infection by SARS-CoV-2 compared to single-dose injections w...

Descripción completa

Detalles Bibliográficos
Autores principales: Crutcher, Madison, Seidler, Paul M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618920/
https://www.ncbi.nlm.nih.gov/pubmed/34835158
http://dx.doi.org/10.3390/vaccines9111229
_version_ 1784604864507019264
author Crutcher, Madison
Seidler, Paul M.
author_facet Crutcher, Madison
Seidler, Paul M.
author_sort Crutcher, Madison
collection PubMed
description Two of the three COVID-19 vaccines approved in the United States require two doses to reach full efficacy, as do others available elsewhere in the world. The complete series of multidose COVID-19 vaccines offers stronger protection against infection by SARS-CoV-2 compared to single-dose injections with the same vaccines. Achieving perfect community-level adherence is a challenge in any public health campaign, even in non-pandemic times. Vaccines requiring multiple doses combined with a surge of vaccine hesitancy and misinformation that has been witnessed by the public during the COVID-19 pandemic are exacerbating the challenge of ensuring the world’s population achieves a sufficient level of immunity against COVID-19. Here, we describe the results of our study in which we sought to determine whether completion of a two-dose COVID-19 vaccine regimen could be improved by disseminating infographics that explain what the vaccine is and why returning for the second dose is beneficial. Our results show that the proportion of COVID-19 vaccine recipients returning for a second inoculation grew after COVID-19 vaccine infographics were distributed to first-time vaccine recipients. We suggest that extending communication and outreach initiatives into the clinic positively influences the rate of follow-up visits, and that infographics are useful tools to aid and bolster the deployment of COVID-19 vaccines.
format Online
Article
Text
id pubmed-8618920
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86189202021-11-27 Maximizing Completion of the Two-Dose COVID-19 Vaccine Series with Aid from Infographics Crutcher, Madison Seidler, Paul M. Vaccines (Basel) Communication Two of the three COVID-19 vaccines approved in the United States require two doses to reach full efficacy, as do others available elsewhere in the world. The complete series of multidose COVID-19 vaccines offers stronger protection against infection by SARS-CoV-2 compared to single-dose injections with the same vaccines. Achieving perfect community-level adherence is a challenge in any public health campaign, even in non-pandemic times. Vaccines requiring multiple doses combined with a surge of vaccine hesitancy and misinformation that has been witnessed by the public during the COVID-19 pandemic are exacerbating the challenge of ensuring the world’s population achieves a sufficient level of immunity against COVID-19. Here, we describe the results of our study in which we sought to determine whether completion of a two-dose COVID-19 vaccine regimen could be improved by disseminating infographics that explain what the vaccine is and why returning for the second dose is beneficial. Our results show that the proportion of COVID-19 vaccine recipients returning for a second inoculation grew after COVID-19 vaccine infographics were distributed to first-time vaccine recipients. We suggest that extending communication and outreach initiatives into the clinic positively influences the rate of follow-up visits, and that infographics are useful tools to aid and bolster the deployment of COVID-19 vaccines. MDPI 2021-10-22 /pmc/articles/PMC8618920/ /pubmed/34835158 http://dx.doi.org/10.3390/vaccines9111229 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Communication
Crutcher, Madison
Seidler, Paul M.
Maximizing Completion of the Two-Dose COVID-19 Vaccine Series with Aid from Infographics
title Maximizing Completion of the Two-Dose COVID-19 Vaccine Series with Aid from Infographics
title_full Maximizing Completion of the Two-Dose COVID-19 Vaccine Series with Aid from Infographics
title_fullStr Maximizing Completion of the Two-Dose COVID-19 Vaccine Series with Aid from Infographics
title_full_unstemmed Maximizing Completion of the Two-Dose COVID-19 Vaccine Series with Aid from Infographics
title_short Maximizing Completion of the Two-Dose COVID-19 Vaccine Series with Aid from Infographics
title_sort maximizing completion of the two-dose covid-19 vaccine series with aid from infographics
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618920/
https://www.ncbi.nlm.nih.gov/pubmed/34835158
http://dx.doi.org/10.3390/vaccines9111229
work_keys_str_mv AT crutchermadison maximizingcompletionofthetwodosecovid19vaccineserieswithaidfrominfographics
AT seidlerpaulm maximizingcompletionofthetwodosecovid19vaccineserieswithaidfrominfographics